Risankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
Asthma affects more than 300 million persons worldwide, and its prevalence is increasing. Severe asthma affects approximately 5 to 10% of persons with asthma. Patients with severe asthma have poor disease control and frequent exacerbations in spite of treatment with high-dose inhaled ..read more
Visit website
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
Currently available biologic therapies targeting IgE, interleukin-4 and -13, and interleukin-5 are effective in treating moderate-to-severe type 2 asthma. However, many patients with type 2 or non–type 2 asthma continue to have symptoms, exacerbations, and reduced lung function. Therefore, new ..read more
Visit website
Clinical Translation of Basic Science in Asthma
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
Basic science has enriched our understanding of the pathophysiology of severe asthma. Clinical translation of these discoveries has resulted in biologic therapies that target key components of asthma-related disease pathways. For example, identification and validation of biomarkers such as elevated ..read more
Visit website
Autoimmune Hemolytic Anemias
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
Autoimmune hemolytic anemia (AIHA) is defined as increased destruction of red cells through autoimmune mechanisms, usually mediated by autoantibodies against erythrocyte surface antigens. During the past decade, important new findings have emerged regarding the cause, pathogenesis, diagnosis, and ..read more
Visit website
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
Crohn’s disease and ulcerative colitis, together referred to as inflammatory bowel disease (IBD), are chronic systemic inflammatory disorders. These conditions target primarily the gastrointestinal tract but can affect many organ systems through extraintestinal manifestations (e.g. peripheral and ..read more
Visit website
Symblepharon in Linear IgA Bullous Dermatosis
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
Figure 1 ..read more
Visit website
MMR Vaccine–Associated Disseminated Measles in an Immunocompromised Adolescent
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
To the Editor: Since the U.S. measles immunization program began in 1963, death from vaccine-associated measles is extremely rare, and endemic measles has nearly been eliminated. Vaccine reactions after administration of the measles–mumps–rubella (MMR) vaccine are generally mild and may include ..read more
Visit website
Challenges of Sarcoidosis and Its Management
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
Sarcoidosis is an inflammatory, multisystemic disease of unknown cause with a wide range of clinical manifestations. The disorder can affect virtually any organ in the body — predominantly the lungs, lymphatic system, skin, or eyes or a combination of these sites — and is characterized by the ..read more
Visit website
Amoxicillin Rash in Infectious Mononucleosis
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
Figure 1 ..read more
Visit website
Environmental Racism and Climate Change — Missed Diagnoses
The New England Journal of Medicine : Allergy/Immunology articles
by
2y ago
The mother clutches her daughter as the nebulized albuterol permeates the young girl’s airways. My eyes dart between the monitor and the child’s small, dark-skinned chest as it heaves up and down at an alarming rate. I smile reassuringly, but the mother’s eyes begin to well with tears as she ..read more
Visit website

Follow The New England Journal of Medicine : Allergy/Immunology articles on FeedSpot

Continue with Google
Continue with Apple
OR